Patient safety is not an afterthought; it is the foundation of every clinical trial.

On World Patient Safety Day 2025, we reaffirm our commitment to safeguarding every participant who takes part in our studies.

At Richmond Pharmacology, pharmacovigilance is central to this.

  • Every event is recorded and reviewed with care
  • Our safety team and Principal Investigators work tirelessly to ensure no safety signals are overlooked
  • Rigorous oversight protects today’s participants and tomorrow’s patients

Explore our new infographic to see how drug safety monitoring works in practice and why it matters.

Latest news

Participant-Centred Recruitment and Retention: Driving Faster Answers in Clinical Trials.

December 18, 2025
Richmond Pharmacology is proud to announce the publication of an editorial by Elizabeth Romano, Director of Communications and Participant Engagement, in the Winter 2025 issue of the Journal for Clinical Studies.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event